LPA2 antagonist 1
Mocravimod hydrochloride
Melanotan I acetate
Pomaglumetad methionil anhydrous
IPI-504 hydrochloride
JNK Inhibitor IX(SC202671)
ZJ43
cis-ACPD
JNJ-5207787
RWJ-56110
MAT2A-IN-3
L-Arginine-13C6 hydrochloride
Pembrolizumab(anti-PD-1)
diABZI-C2-NH2
Motolimod
P-gp inhibitor 4
Amifampridine phosphate
Solnatide
ML-SI3
GSK205
Anagliptin hydrochloride
Teneligliptin-d8
Nortriptyline
BI8622
YM-53601 free base
Simvastatin hydroxy acid sodium
Fluvastatin-d6 sodium
BMS-986242
3-Hydroxycoumarin
Larsucosterol
Spironolactone-d7
Apigenin-7-glucuronide
β-Anhydroicaritin
MSI-1436
Rhynchophylline
RXR antagonist 2
BMS-195614
NEP-In-1
D-Galactose(D-(+)-Galactose)
PF-2545920
Miconazole Nitrate
MAO-B-IN-6
MAO-B-IN-9
Duloxetine metabolite Para-Naphthol Duloxetine
UTPγS trisodium salt
Galanin(1-30)(human)
Sigma-1 receptor antagonist 3
Antitumor agent-55
Ningetinib Tosylate
Ramucirumab
Boc-Val-Cit-PAB
Asymmetric dimethylarginine
Hypocrellin C
Mogroside III
Citric acid monohydrate
Indophagolin
L-NMMA acetate
IMP-1088
Bulleyaconitine A
Buddlejasaponin IVb
